New Research Study For Adults With Chronic Ocular Surface Pain (COSP)

The pre-screening questionnaire asks health-related questions to determine whether you meet the initial qualifications for a chronic ocular surface pain (COSP) study. Certain terms must be met before study participation can begin to help ensure the safety of individuals and the success of the clinical study.

If you do meet those qualifications, you will be connected to a study doctor and a dedicated research team. You will also receive additional study information, have an opportunity to ask questions, and be invited to meet with a trial doctor at an in-person clinic visit.

The health questionnaire takes about 5-8 minutes to complete.

Unfortunately, you have not met the pre-screening requirements.

Based on the answers you provided, this opportunity may not be a good fit for you.

There are specific requirements for every clinical study, to ensure the safety of the participants who are involved.

Don’t lose hope! All clinical studies are different, and just because this one isn’t a good fit does not mean you won’t qualify for another study. Your doctor and care team can help you find a clinical study that is more appropriate for you.

Thank you for your time, and for expressing your interest in joining our research community!

Congratulations on passing our pre-screening questionnaire!

Based on your answers, you may be a good fit for a study to help find better solutions for eye pain. We are thrilled to have you join our network of volunteers shaping the future of eye pain research.

We will notify you as soon as the screening process starts.

Once screening is active, a representative from the Responsum Health team will connect you with a dedicated research team near you, including a doctor who is conducting the study. The study doctor will give you additional information and answer any questions you may have. They may ask you more health-related questions, and invite you to their clinic for an in-person visit.

In the meantime, check your email for more updates and useful information from us regarding the clinical trial process, chronic eye pain, and more!

0 of 10 answered